270 related articles for article (PubMed ID: 7598629)
21. An Oldie but Goodie: Lithium in the Treatment of Bipolar Disorder through Neuroprotective and Neurotrophic Mechanisms.
Won E; Kim YK
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29232923
[TBL] [Abstract][Full Text] [Related]
22. Effects of lithium on second messenger systems in the brain.
Mørk A; Geisler A; Hollund P
Pharmacol Toxicol; 1992; 71 Suppl 1():4-17. PubMed ID: 1336196
[No Abstract] [Full Text] [Related]
23. Ziskind-Somerfeld research Award. The involvement of guanine nucleotide binding proteins in the pathogenesis and treatment of affective disorders.
Avissar S; Schreiber G
Biol Psychiatry; 1992 Mar; 31(5):435-59. PubMed ID: 1581423
[TBL] [Abstract][Full Text] [Related]
24. Calcium homeostasis in long-term lithium-treated women with bipolar affective disorder.
El Khoury A; Petterson U; Kallner G; Aberg-Wistedt A; Stain-Malmgren R
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1063-9. PubMed ID: 12452527
[TBL] [Abstract][Full Text] [Related]
25. Neurobiological Considerations of the mode of action of lithium carbonate in the treatment of affective disorders?
Bunney WE; Murphy DL
Pharmakopsychiatr Neuropsychopharmakol; 1976 May; 9(3):142-7. PubMed ID: 185630
[TBL] [Abstract][Full Text] [Related]
26. A genetic network model of cellular responses to lithium treatment and cocaine abuse in bipolar disorder.
McEachin RC; Chen H; Sartor MA; Saccone SF; Keller BJ; Prossin AR; Cavalcoli JD; McInnis MG
BMC Syst Biol; 2010 Nov; 4():158. PubMed ID: 21092101
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of PKC alpha by lithium in vitro.
Bitran JA; Manji HK; Potter WZ; Gusovsky F
Psychopharmacol Bull; 1995; 31(2):449-52. PubMed ID: 7491404
[TBL] [Abstract][Full Text] [Related]
28. Ziskind-Somerfeld Research Award. Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness.
Manji HK; Lenox RH
Biol Psychiatry; 1999 Nov; 46(10):1328-51. PubMed ID: 10578449
[TBL] [Abstract][Full Text] [Related]
29. Cellular plasticity cascades: genes-to-behavior pathways in animal models of bipolar disorder.
Einat H; Manji HK
Biol Psychiatry; 2006 Jun; 59(12):1160-71. PubMed ID: 16457783
[TBL] [Abstract][Full Text] [Related]
30. The effect of lithium on the adrenoceptor-mediated second messenger system in the rat brain.
Devaki R; Shankar Rao S; Nadgir SM
J Psychiatry Neurosci; 2006 Jul; 31(4):246-52. PubMed ID: 16862242
[TBL] [Abstract][Full Text] [Related]
31. Signaling: cellular insights into the pathophysiology of bipolar disorder.
Manji HK; Lenox RH
Biol Psychiatry; 2000 Sep; 48(6):518-30. PubMed ID: 11018224
[TBL] [Abstract][Full Text] [Related]
32. Exploring lithium's transcriptional mechanisms of action in bipolar disorder: a multi-step study.
Akkouh IA; Skrede S; Holmgren A; Ersland KM; Hansson L; Bahrami S; Andreassen OA; Steen VM; Djurovic S; Hughes T
Neuropsychopharmacology; 2020 May; 45(6):947-955. PubMed ID: 31652432
[TBL] [Abstract][Full Text] [Related]
33. New Advances in the Pharmacology and Toxicology of Lithium: A Neurobiologically Oriented Overview.
Bortolozzi A; Fico G; Berk M; Solmi M; Fornaro M; Quevedo J; Zarate CA; Kessing LV; Vieta E; Carvalho AF
Pharmacol Rev; 2024 May; 76(3):323-357. PubMed ID: 38697859
[TBL] [Abstract][Full Text] [Related]
34. The effects of lithium on ex vivo cytokine production.
Rapaport MH; Manji HK
Biol Psychiatry; 2001 Aug; 50(3):217-24. PubMed ID: 11513821
[TBL] [Abstract][Full Text] [Related]
35. G protein-mediated signal transduction as a target of antidepressant and antibipolar drug action: evidence from model systems.
Rasenick MM; Chaney KA; Chen J
J Clin Psychiatry; 1996; 57 Suppl 13():49-55; discussion 56-8. PubMed ID: 8970504
[TBL] [Abstract][Full Text] [Related]
36. Rhythms and the pharmacology of lithium.
Klemfuss H
Pharmacol Ther; 1992; 56(1):53-78. PubMed ID: 1297145
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic Mechanisms of Lithium in Bipolar Disorder: Recent Advances and Current Understanding.
Malhi GS; Outhred T
CNS Drugs; 2016 Oct; 30(10):931-49. PubMed ID: 27638546
[TBL] [Abstract][Full Text] [Related]
38. Lithium does not prevent agonist-induced subsensitivity of human adenylate cyclase.
Zohar J; Lerer B; Ebstein RP; Belmaker RH
Biol Psychiatry; 1982 Mar; 17(3):343-50. PubMed ID: 6282346
[TBL] [Abstract][Full Text] [Related]
39. Molecular basis of lithium action: integration of lithium-responsive signaling and gene expression networks.
Lenox RH; Wang L
Mol Psychiatry; 2003 Feb; 8(2):135-44. PubMed ID: 12610644
[TBL] [Abstract][Full Text] [Related]
40. Molecular targets of lithium action.
Corbella B; Vieta E
Acta Neuropsychiatr; 2003 Dec; 15(6):316-40. PubMed ID: 26983769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
